ArriVent BioPharma
AVBP
AVBP
68 hedge funds and large institutions have $612M invested in ArriVent BioPharma in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
68
Holders Change
+14
Holders Change %
+25.93%
% of All Funds
0.98%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
16
Increased
38
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$45.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$31.6M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$14M |
4 |
4
State Street
Boston,
Massachusetts
|
$11.2M |
5 |
5
Millennium Management
New York
|
$5.09M |